Diagnostic tunnel vision by 2 pulmonologists led to a $2 million malpractice settlement after the patient died of esophageal cancer.
What you need to know:Dr Ronald Mabubi, a neurosurgeon at JRRH, said in the past, nearly 90 percent of patients referred from the facility did not survive, largely due to delays in accessing ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines the diagnostic performance of PYLARIFY ® (piflufolastat F 18) with the potential for larger ...
Impact of FGFR3 alterations on first-line platinum based chemotherapy in patients with metastatic or locally advanced urothelial carcinoma: The retrospective IFUCA study. Phase 2 trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results